EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbiome–Metabolome Axis in BALF Reveals Novel Diagnostic Biomarkers for Congenital Heart Disease-Associated Pulmonary Arterial Hypertension

Xiaoyu Zhang, Liming Cheng, Yuan Zhou, Jiahui Xie, Wenting Gui, Jiaxiang Chen, Zidan Zhang, Kai Liu, Runwei Ma

Journal of Cardiovascular Development and Disease · 06.01.2026 · 13 (1) · 32

DOI: 10.3390/jcdd13010032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 06.01.2026. Verfasst von Xiaoyu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences/Affiliated Cardiovascular Hospital of Kunming Medical Unive…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Provincial Department of Science and Technology Kunming Medical University Applied Basic Research Joint Project, Program of Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early identification of irreversible pulmonary vascular remodeling in congenital heart disease-associated pulmonary arterial hypertension (C-PAH) is critical for optimizing surgical timing. Current noninvasive diagnostic methods are inadequate, and the lung microbiome and metabolome may provide novel insights into disease progression.

Methods

We analyzed bronchoalveolar lavage fluid (BALF) from 47 children, including those with C-PAH (n = 15), CHD without PAH (C-NPAH, n = 16), and healthy controls (n = 16), using 16S rRNA gene sequencing and untargeted metabolomics. Differential microbial taxa and metabolites were identified, and their interactions with clinical indicators were assessed via Random Forest (RF) and Mediation Analysis.

Results

C-PAH patients exhibited airway microbial dysbiosis, characterized by an elevated Firmicutes/Bacteroidetes (F/B) ratio and increased abundance of g_Lactobacillus. Metabolomic profiling revealed 88 differential metabolites between C-PAH and controls, and 3 between C-PAH and C-NPAH. N1-methylnicotinamide (MNAM) and 2-piperidone emerged as potential biomarkers. Mediation analysis showed that g_Eikenella influenced PAH indirectly through 2-piperidone (β = −0.376, p = 0.026), indicating a microbe–metabolite–host interaction.

Conclusions

Integrative microbiome–metabolome profiling of BALF reveals potential biomarkers for C-PAH. These findings provide exploratory evidence that microbial and metabolic biomarkers, particularly 2-piperidone and MNAM, hold potential for the early, noninvasive identification of irreversible pulmonary vascular remodeling, but require further validation in independent cohorts.

Schlagwörter

Stichwörter der Autor:innen

biomarkercongenital heart diseasemediation analysismetabolomicsmicrobiomepulmonary arterial hypertension

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences/Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming 650032, China.
  • Department of Anesthesiology, Kunming Children's Hospital, Kunming 650034, China.
  • Department of Comprehensive Pediatrics, Kunming Children's Hospital, Kunming 650034, China.

Förderung

  • National Natural Science Foundation of China
  • Yunnan Provincial Department of Science and Technology Kunming Medical University Applied Basic Research Joint Project
  • Program of Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences
  • Scientific Research Project of Yunnan Cardiovascular Disease Clinical Medical Center

Zitieren

APA

Zhang, X., Cheng, L., Zhou, Y., Xie, J., Gui, W., Chen, J., Zhang, Z., Liu, K., & Ma, R. (2026). Microbiome–Metabolome Axis in BALF Reveals Novel Diagnostic Biomarkers for Congenital Heart Disease-Associated Pulmonary Arterial Hypertension. Journal of Cardiovascular Development and Disease, 13(1), 32. https://doi.org/10.3390/jcdd13010032

Vancouver

Zhang X, Cheng L, Zhou Y, Xie J, Gui W, Chen J, et al. Microbiome–Metabolome Axis in BALF Reveals Novel Diagnostic Biomarkers for Congenital Heart Disease-Associated Pulmonary Arterial Hypertension. Journal of Cardiovascular Development and Disease. 2026;13(1):32. doi:10.3390/jcdd13010032

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaoyu and Cheng, Liming and Zhou, Yuan and Xie, Jiahui and Gui, Wenting and Chen, Jiaxiang and Zhang, Zidan and Liu, Kai and Ma, Runwei},
  title = {Microbiome–Metabolome Axis in BALF Reveals Novel Diagnostic Biomarkers for Congenital Heart Disease-Associated Pulmonary Arterial Hypertension},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {32},
  doi = {10.3390/jcdd13010032}
}
Kostenlos starten →